Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

Conditions:   Oropharyngeal Carcinoma;   HPV Positive Oropharyngeal Squamous Cell Carcinoma
Interventions:   Radiation: Standard Radiation Treatment;   Radiation: Dose-Deescalated Treatment;   Drug: Cisplatinum
Sponsor:   New York University School of Medicine
Recruiting - verified July 2017

http://ift.tt/2uia4Mo